Skip to content
UK Reviews Future of Prostate Cancer Screening
Public consultation opens on targeted prostate cancer screening recommendations – shaping future UK policy for early detection and high-risk groups.
£6M Lab Investment Signals Midlands Growth
Warwick Science Park expands lab facilities – easing space shortages and strengthening the Midlands as a rising hub for UK research.
The 3 Traits Every Strong Lab Culture Shares
Great labs aren’t built on equipment alone – they thrive on communication, trust, and real appreciation among the people doing the work.
Global Study Proposes New Grading System for Lung Squamous Cell Carcinoma
The International Association for the Study of Lung Cancer (IASLC) Pathology Committee has proposed a new, simplified grading system for invasive lung squamous cell carcinoma (LUSC). The system, focused on tumour budding, offers a more accurate way to assess prognosis. LUSC makes up about a quarter of all lung cancers, but treatment options remain limited […]
Ataraxis and MEDSIR Launch AI Platform to Transform Breast Cancer Trials
Ataraxis AI, a laboratory pioneering AI-powered oncology tools, has announced a strategic collaboration with Medica Scientia Innovation Research (MEDSIR) to bring artificial intelligence into international breast cancer trials. The collaboration spans data from over 1,000 patients across randomised clinical trials. Its aim: identify biomarkers to optimise treatment strategies, including therapies with CDK4/6 inhibitors and antibody-drug […]
Peptide ‘Switch’ Shows Promise in Halting Parkinson’s Protein Build-Up
A breakthrough peptide fragment could stabilise Parkinson’s-linked proteins, preventing toxic clumps and restoring movement in early animal models.
Smooth Snake comeback: rare reptile thrives in Devon reintroduction project
Devon’s Smooth Snake population is rising fast thanks to conservation efforts, habitat restoration, and dedicated volunteers safeguarding heathlands.
Unified NHS AI platform to transform cancer screening research
A £6 million NIHR-funded platform will allow NHS trusts to test AI screening tools nationwide, cutting costs and delays.
NHS shifts to ‘patient-first’ approach in medical technology buying
New NHS procurement strategy prioritises patient outcomes, safety, and long-term value over lowest price, opening doors for medtech innovation.
Scientists uncover hidden protein blocking cancer immunotherapy success
Researchers identify sClever-1 as a hidden protein undermining immunotherapy — and show a new antibody may restore treatment effectiveness.
£15bn boost could spark wave of UK lab spin-outs beyond Oxford, Cambridge & London
A £15bn funding plan could generate 1,700 new spin-outs and 56,000 jobs — if investment spreads beyond the ‘golden triangle’.
Oral bacteria and fungi linked to 3.5x higher pancreatic cancer risk, major study finds
Oral microbes, including Candida fungi, may triple pancreatic cancer risk — offering new potential for early screening and personalised prevention strategies.
LabOS Expands AI-Driven LIS Platform with New Add-On Modules
LabOS expands its AI-driven LIS with new physician and courier modules, boosting efficiency, compliance, and patient-focused laboratory workflows.
Ultra-clean graphene breakthrough unlocks hidden quantum effects
Researchers at the NGI have developed ultra-clean graphene, eliminating interference and opening new doors in superconductivity, magnetism, and quantum phenomena.
NHS home testing hits 100,000 milestone in hepatitis C fight
The NHS home testing service has reached 100,000 users, preventing serious illness and bringing England closer to eliminating hepatitis C.
AI uncovers hidden signs of prostate cancer years before diagnosis
Uppsala researchers show AI can detect prostate cancer long before it’s visible to pathologists, helping reduce missed diagnoses and save lives.
Toolsquare gives you insight and control over the use of your equipment
Toolsquare’s smart monitoring system logs usage, boosts accountability, reduces downtime, and gives managers real-time insights for better investment decisions.
Plasma and Serum Viscosity Testing: The Modern Diagnostic Tool Healthcare Can’t Afford to Ignore
Plasma and serum viscosity testing is emerging as a faster, more accurate alternative to outdated inflammation markers like ESR and CRP, offering improved reliability, resistance to drug interference, and rapid results that meet the demands of modern healthcare.
WHO sets standards for newborn infection diagnostics
WHO has released new standards for affordable newborn infection diagnostics, aiming to save lives through earlier detection and improved treatment decisions.
NHS launches world-first gonorrhoea vaccine roll-out
The NHS will offer a free gonorrhoea vaccine to high-risk patients from August 2025, aiming to curb record infections and antibiotic resistance.